Homeβ€ΊSearchβ€ΊCancer Imaging

Cancer Imaging

BioMed Central Ltd Β· United Kingdom Β· Est. 2000

ISSN1740-5025eISSN1470-7330
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
9
weeks to publish Β· journal-reported
Fast Β· vs ~15 wk median
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
1.16
H-Indexi
81
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
1.074
Total Worksi
2,016
Total Citationsi
39,117
2yr Mean Citednessi
4.34
Open Impact Factor alternative

Aims & Scope

Subject areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging; Medicine (miscellaneous); Radiological and Ultrasound Technology; Radiology, Nuclear Medicine and Imaging.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published2000
FrequencyTwo No. A Year
StatusActive (last: 2026)
Total Publications2,016
Publisher OrgBioMed Central
OA Since2013
Visit Journal Website

Submission Info

Peer ReviewPeer review
Review Time~9 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC0
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
LOCKSSPMCCLOCKSS

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
BioMed Central Ltd
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1740-5025 / 1470-7330
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Peer review
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
LOCKSS, PMC, CLOCKSS
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
94
3.5k
2019
87
3.3k
2020
68
1.5k
2021
78
1.2k
2022
127
1.5k
2023
173
1.6k
2024
162
453
2025
103
16
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Medicine (miscellaneous)Q1
Radiological and Ultrasound TechnologyQ1
Radiology, Nuclear Medicine and ImagingQ1
OncologyQ2

Subject Classification

Web of Science Categories

OncologyRadiology, Nuclear Medicine & Medical Imaging

Scopus Categories

Radiology, Nuclear Medicine and ImagingOncologyMedicine (miscellaneous)Radiological and Ultrasound Technology

Research Topics (OpenAlex)

Radiomics and Machine Learning in Medical ImagingMRI in cancer diagnosisMedical Imaging Techniques and ApplicationsLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisGlioma Diagnosis and TreatmentHead and Neck Cancer StudiesAdvanced X-ray and CT ImagingProstate Cancer Diagnosis and TreatmentPancreatic and Hepatic Oncology Research

Frequently asked questions about Cancer Imaging

Is Cancer Imaging a predatory journal?

PubScope has no integrity flags on record for Cancer Imaging: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Cancer Imaging?

Cancer Imaging is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.34.

Is Cancer Imaging indexed in Scopus and Web of Science?

Cancer Imaging is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Cancer Imaging?

Subject areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging; Medicine (miscellaneous); Radiological and Ultrasound Technology; Radiology, Nuclear Medicine and Imaging.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref